What type of study is this?

This is a Systematic Review study (also classified as: Meta-Analysis, Human Clinical Trial, RCT, Animal Study).

August 22, 2025Frontiers in PharmacologyOpen Access

Potential therapeutic benefits of curcumin in depression or anxiety induced by chronic diseases: a systematic review of mechanistic and clinical evidence

View Full Paper

Ask AI

Bookmark

Authors

JYJiyuan Yuan CPChao Pi HSHongping Shen

Discussion

Member takes

Overview

Systematic review demonstrates curcumin's significant effects on depression and anxiety symptoms in chronic diseases, indicating its potential as a treatment.

Key Points

Curcumin significantly reduces depressive symptoms in patients with chronic diseases, improving their overall quality of life.
In meta-analysis, curcumin displayed a standardized mean difference of -0.65 for depression and -0.22 for anxiety using data from 15 RCTs with 1,123 participants.
This systematic review employs a meta-analysis approach, combining both clinical trial and preclinical data to explore curcumin's efficacy and mechanisms.
These findings support curcumin as a complementary treatment for depression and anxiety, though variability in studies and treatment may limit conclusions.

Cite This Study

Yuan et al. (2025) studied this question.

synapsesocial.com/papers/68af55c6ad7bf08b1eadbc56 https://doi.org/10.3389/fphar.2025.1638645

View Full Paper

Ask AI

Bookmark

August 22, 2025Frontiers in PharmacologyOpen Access

Potential therapeutic benefits of curcumin in depression or anxiety induced by chronic diseases: a systematic review of mechanistic and clinical evidence

View Full Paper

Ask AI

Bookmark

Authors

JYJiyuan Yuan CPChao Pi HSHongping Shen

Discussion

Member takes

Overview

Systematic review demonstrates curcumin's significant effects on depression and anxiety symptoms in chronic diseases, indicating its potential as a treatment.

Key Points

Curcumin significantly reduces depressive symptoms in patients with chronic diseases, improving their overall quality of life.
In meta-analysis, curcumin displayed a standardized mean difference of -0.65 for depression and -0.22 for anxiety using data from 15 RCTs with 1,123 participants.
This systematic review employs a meta-analysis approach, combining both clinical trial and preclinical data to explore curcumin's efficacy and mechanisms.
These findings support curcumin as a complementary treatment for depression and anxiety, though variability in studies and treatment may limit conclusions.

Cite This Study

Yuan et al. (2025) studied this question.

synapsesocial.com/papers/68af55c6ad7bf08b1eadbc56 https://doi.org/10.3389/fphar.2025.1638645

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark